Similarly, survival for SRC compared with non-SRC GC was also not significantly different for stage 2 (11.8 vs. 10.6 years; P = 0.619) or stage 3 (4.1 vs. 7.3 years; P = 0.223) (Fig. 2). This evidence concerns the gene SRC and gastric cancer.